Clearstead Advisors’s Veracyte VCYT Stock Holding History

Clearstead Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$999	Buy	+17	New	+$713	﹤0.01%	2691
2026 Q1	–	Sell	-30	Closed	-$1.26K	–	2833
2025 Q4	$1.26K	Buy	+30	New	+$1.21K	﹤0.01%	2201
2025 Q3	–	Sell	-70	Closed	-$1.89K	–	3253
2025 Q2	$1.89K	Hold	70	–	–	﹤0.01%	2338
2025 Q1	$2.08K	Buy	70 +35	+100%	+$1.33K	﹤0.01%	1897
2024 Q4	$1.39K	Buy	+35	New	+$1.32K	﹤0.01%	1890
2024 Q3	–	Sell	-228	Closed	-$4.94K	–	2114
2024 Q2	$4.94K	Buy	+228	New	+$4.79K	﹤0.01%	1689
2021 Q4	–	Sell	-339	Closed	-$16K	–	1440
2021 Q3	$16K	Buy	+339	New	+$14.8K	﹤0.01%	875
2020 Q4	–	Sell	-400	Closed	-$13K	–	1024
2020 Q3	$13K	Buy	+400	New	+$12.7K	﹤0.01%	635

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clearstead Advisors's VCYT Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Veracyte (VCYT) in Q2 2026: 17 shares worth $999. The stake represents ﹤0.01% of the portfolio and ranks #2691 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in VCYT as recently as Q4 2025.

Clearstead Advisors first reported a position in VCYT in Q3 2020 and has held it in 8 quarters since. The position peaked at $16K in Q3 2021. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Clearstead Advisors held 17 shares of Veracyte worth $999 as of Q2 2026.
Veracyte was a new Clearstead Advisors position in Q2 2026.
Veracyte made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2691 holding.
Clearstead Advisors first reported a position in Veracyte in Q3 2020 and has held it in 8 quarters since.
Clearstead Advisors's Veracyte position peaked at $16K in Q3 2021.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.